Vascular diseases, and hypertension remains a major cause of mortality in the US. Furthermore, individuals with metabolic syndromes are at an even greater risk of sequelae, such as a heart attack. While we have learned significant information over the years on some of the factors that contribute to vascular disease, we have large gaps in understanding about how specific cell types are recruited or activated in vascular lesions, atherosclerosis, crosstalk between cell types, regulation of vascular tone, and how these might be altered by metabolic conditions such as obesity. This overall program project addresses the intricate functions of key membrane channel, Panx1, which link many of these steps (both in physiology and pathology); Our studies over the ongoing funding period has already suggest that these channels are 'druggable' and can be relevant hypertesion. The focus of this PO1 application is to understand the role of Pannexin channels in vascular physiology and inflammation. Project 1 will study how Panx1 regulates inflammation in different tissue contexts. Project 2 will investigate Panx1 expression in the vascular smooth muscle cells affects hypertension. Project 3 will address the role of Panx1 in cellular crosstalk in the context of diet-induced cadiometabolic syndrome. Project 4 will address the mechanistic details of pannexin channel function using a variety of approaches. The Mouse Core B will provide support for the overall animal studies, while the Cell Physiology Core Cwill help with pannexin channel analysis in different cell types of relevance. The purpose of this Administrative Core (Core A) is to coordinate the different parts of this PPG by providing scientific administration, grant and fiscal management, statistical and computer/data support, and overall coordination of internal and external scientific advisory meetings.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL120840-06
Application #
9633553
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
OH, Youngsuk
Project Start
Project End
Budget Start
2019-06-01
Budget End
2020-05-31
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Adamson, Samantha E; Montgomery, Garren; Seaman, Scott A et al. (2018) Myeloid P2Y2 receptor promotes acute inflammation but is dispensable for chronic high-fat diet-induced metabolic dysfunction. Purinergic Signal 14:19-26
Kerur, Nagaraj; Fukuda, Shinichi; Banerjee, Daipayan et al. (2018) cGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nat Med 24:50-61
Morioka, Sho; Perry, Justin S A; Raymond, Michael H et al. (2018) Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release. Nature 563:714-718
Brown, Isola A M; Diederich, Lukas; Good, Miranda E et al. (2018) Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension. Arterioscler Thromb Vasc Biol 38:1969-1985
Penberthy, Kristen K; Lysiak, Jeffrey J; Ravichandran, Kodi S (2018) Rethinking Phagocytes: Clues from the Retina and Testes. Trends Cell Biol 28:317-327
Chiu, Yu-Hsin; Schappe, Michael S; Desai, Bimal N et al. (2018) Revisiting multimodal activation and channel properties of Pannexin 1. J Gen Physiol 150:19-39
DeLalio, Leon J; Keller, Alexander S; Chen, Jiwang et al. (2018) Interaction Between Pannexin 1 and Caveolin-1 in Smooth Muscle Can Regulate Blood Pressure. Arterioscler Thromb Vasc Biol 38:2065-2078
Nyberg, Michael; Piil, Peter; Kiehn, Oliver T et al. (2018) Probenecid Inhibits ?-Adrenergic Receptor-Mediated Vasoconstriction in the Human Leg Vasculature. Hypertension 71:151-159
Serbulea, Vlad; Upchurch, Clint M; Ahern, Katelyn W et al. (2018) Macrophages sensing oxidized DAMPs reprogram their metabolism to support redox homeostasis and inflammation through a TLR2-Syk-ceramide dependent mechanism. Mol Metab 7:23-34
Good, Miranda E; Chiu, Yu-Hsin; Poon, Ivan K H et al. (2018) Response by Good et al to Letter Regarding Article, ""Pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone"". Circ Res 122:e88-e89

Showing the most recent 10 out of 38 publications